Thoracic Cancer Patients Find New Reasons for Hope with Alimta(R)
Barcelona (ots/PRNewswire) - - New data may provide important treatment advances in mesothelioma and lung cancer Patients with a cancer of the lining of the lung, known as malignant pleural mesothelioma (MPM), lived longer than ...
Thoracic Cancer Patients Find New Reasons for Hope with Alimta(R)
Patients with a cancer of the lining of the lung, known as malignant pleural mesothelioma (MPM), lived longer than previously reported(1), when treated with Eli Lilly and Company's Alimta(R) (pemetrexed) in combination with cisplatin, according to updated data presented today at the 11th annual Conference on Lung Cancer (WCLC).
Japanese firm says asbestos may have killed 141 workers
A major Japanese building materials maker said that 141 of its employees and pensioners died between 1976 and 2004 of lung diseases believed to have been caused by asbestos.
Nichias Says 141 Deaths Linked to Asbestos
Japanese insulation materials maker Nichias Corp. said Tuesday that 141 employees, mostly plant and construction workers, have died over the last three decades after developing cancer and lung disease likely caused by the company's production of asbestos insulation.
LEAD: 164 workers of 2 firms died of asbestos-linked diseases since 1976
_ (EDS: RECASTING WITH DEATHS AT ANOTHER COMPANY)
Kyodo news summary -8-
_ ---------- 170 workers at 2 firms died of asbestos-linked diseases since 1976
Alliance of Doctors and Mesothelioma Patients Call on Congress to Tailor Awards to Damages, Compensate Swiftly and
An alliance of mesothelioma patients and 34 doctors nationwide who treat them called on each member of the U.S. Senate today to reform serious flaws in the proposed asbestos trust fund bill .
141 Nichias workers die of lung diseases linked to asbestos
_ Building materials maker Nichias Corp. said Tuesday that 141 of its employees died between 1976 and last year of lung cancer, pneumoconiosis and other lung diseases believed to be caused by asbestos, a material used in the company's products.
Alfacell Corporation to Participate in 7th Annual Anti-Cancer Drug Discovery and Development Conference
Alfacell Corporation , a biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for cancer and other life-threatening diseases, today announced that Andrew Aromando, Senior Vice President, Commercial Development and Operations, is a scheduled panelist at Strategic Research Institute's 7th Annual Anti-Cancer Drug Discovery and Development
Senator Specter Breaks Promise to Mesothelioma Patient and Research Community
The mesothelioma research community today expressed great disappointment in Senator Arlen Specter's reluctance to provide additional funding for mesothelioma research at the National Institutes of Health .
No comments:
Post a Comment